Third Straight Pharma Buy Queue in Under a Week: IRDR Hits a One Year High on a 19 Session Run With No Price Moving Codal Disclosure Behind It (Monday, August 24, 2026)

Tehran ticker IRDR just logged its nineteenth straight higher close, and almost nobody is talking about it. This is the nineteenth consecutive session that IRDR has closed higher, without a single down day. The stock has run from eight thousand two hundred ninety rials to fourteen thousand rials. Today's price sits four hundred forty four percent above this stock's own one year low. IRDR's P/E is nine point one four, well below the pharma sector's twelve point nine eight. Right now, IRDR's valuation still sits below the average for the whole pharmaceutical sector. Today, retail investors net bought about twenty three point seven million shares. Today's board shows the buy queue closed with over one hundred thousand shares of unmet demand. Sahmino found no price moving material disclosure for IRDR on Codal in the past ninety days. From late June to today, this stock has traced one uninterrupted upward run. Two paths lie ahead for this stock, an official disclosure, or more silence. Here is the key point today, the buy queue is real, but the official explanation is not. Full analysis is on Sahmino dot com. Is this silence a secret about to break, or just retail momentum?